Topic: Pharmaceuticals Sector
LONDON (Reuters) - Western generic drugmakers need to adapt to cope with rapid changes in the pharmaceuticals market that are blurring the distinctions between innovator companies and makers of cheaper copycat products.That is the view of Claudio Albrecht, chief executive of Swiss-based ...
LONDON/PARIS (Reuters) - Three of Europe's biggest drugmakers -- AstraZeneca , Novartis and Sanofi -- reported product setbacks on Tuesday, underlining the difficulties of developing new medicines to make up for those going off patent.With the weakest pipeline of its European peers, ...
NEW YORK (Reuters) - The chief executive of Merck & Co on Tuesday defended his refusal to slash the drugmaker's $8 billion research budget and warned that global price constraints threaten the pharmaceutical industry's ability to innovate.The drug industry is embroiled in ...
LONDON (Reuters) - AstraZeneca is cutting nearly a quarter of its U.S. sales force in a second wave of redundancies in as many months as it seeks to reduce costs.Britain's second biggest drugmaker said on Wednesday it would cut about 1,150 sales ...
LONDON (Reuters) - AstraZeneca is cutting nearly a quarter of its U.S. sales force in a second wave of redundancies in as many months as it seeks to reduce costs.Britain's second biggest drugmaker said on Wednesday it would cut about 1,150 sales ...
(Reuters) - AstraZeneca said it will cut about 1,150 U.S. sales jobs, and expects to take a related charge of about $50-$100 million in the fourth quarter.The company said the job cuts, which will account for about 24 percent of the company's ...
(Reuters) - Drug regulators cited Novartis AG for "significant violations" of manufacturing regulations at its three generic drug plants in the United States and Canada, several of which were repeat offenses.U.S. Food and Drug Administration investigators found a lack of proper procedures ...
WASHINGTON (Reuters) - The government urged the Supreme Court to rule in favor of a generic drugmaker in a case over how companies can fight brand-name rivals to get cheaper drugs to market.The nation's top court on Monday heard arguments about whether ...
LONDON (Reuters) - Regulators and drugmakers need to find ways to make more clinical data openly available, since vital knowledge about fighting disease is often locked away in confidential databases, the head of the U.S. drugs watchdog said on Monday.Food and Drug ...
(Reuters) - A federal appeals court on Thursday refused to revive Teva Pharmaceutical Industries Ltd's patent infringement suit against AstraZeneca Pharmaceuticals LP for the rights to Crestor, a multibillion-dollar cholesterol fighter.In a ruling that upheld a lower court, the U.S. Court of ...
Photo Gallery
-
Art Auction
This photograph provided by Farnsworth Art Museum show the 1969 painting "Portrait ...AP News - -
Pfizer CEO Resigns
FILE - In this Jan. 26, 2009 file photo, Jeffrey Kindler, chairman and ...AP News - -
Eli Lilly Acquisition
FILE - In this Jan. 25, 2006 file photo, the Eli Lilly and ...AP News -
From Around the Web
Video Gallery
-
Pharmaceuticals Industry In India
India is the world's 3rd largest pharmaceutical producer, Cardiovascular ...2011-12-10 -
Indian pharma sector to grow in ...
Kiran Mazumdar Shaw, CMD, Biocon told NDTV Profit that they ...2012-01-09 -
Petroleum and Pharmaceuticals Sector Strike
(www.abndigital.com) Up to 70 thousand workers in the ...2011-07-11
